Pathway-Based analysis of a Melanoma Genome-Wide association study: Analysis of genes related to Tumour-Immunosuppression

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Schoof, Nils ^a,b   Iles, Mark M ^a,c   Bishop, D Timothy ^a,c   Newton Bishop, Julia A ^a,c   Barrett, Jennifer H ^a,c   Mann, Graham J ^c   Hopper, John L ^c   Aitken, Joanne F ^c   Armstrong, Bruce K ^c   Giles, Graham G ^c   Kefford, Richard F ^c   Cust, Anne ^c   Jenkins, Mark ^c   Aguilera, Paula ^c   Badenas, Celia ^c   Carrera, Cristina ^c   Cuellar, Francisco ^c   Gabriel, Daniel ^c   Martinez, Estefania ^c   Gonzalez, Melinda ^c   Iglesias, Pablo ^c   Malvehy, Josep ^c   Marti Laborda, Rosa ^c   Mila, Montse ^c   Ogbah, Zighe ^c   Butille, Joan Anton Puig ^c   Puig, Susana ^c   Alós, Llúcia ^c   Arance, Ana ^c   Arguís, Pedro ^c   Campo, Antonio ^c   Castel, Teresa ^c   Conill, Carlos ^c   Palou, Jose ^c   Rull, Ramon ^c   Sánchez, Marcelo ^c   Vidal Sicart, Sergi ^c   Vilalta, Antonio ^c   Vilella, Ramon ^c   Martin, Nicholas G ^c   Montgomery, Grant W ^c   Duffy, David ^c   Whiteman, David ^c   Macgregor, Stuart ^c   Hayward, Nicholas K ^c   Webb, Penny ^c   Green, Adele ^c   Parsons, Peter ^c   Purdie, David ^c   Landi, Maria Teresa ^c   Calista, Donato ^c   Landi, Giorgio ^c   Minghetti, Paola ^c   Arcangeli, Fabio ^c   Bertazzi, Pier Alberto ^c   Bianchi Scarra, Giovanna ^d   Ghiorzo, Paola ^d   Pastorino, Lorenza ^d   Bruno, William ^d   Battistuzzi, Linda ^d   Gargiulo, Sara ^d   Nasti, Sabina ^d   Gliori, Sara ^d   Origone, Paola ^d   Queirolo, Paola ^e   Mackie, Rona ^c   Lang, Julie ^c   Affleck, Paul ^c   Harrison, Jane ^c   Randerson Moor, Juliette ^c   Harland, Mark ^c   Taylor, John C ^c   Whittaker, Linda ^c   Kukalizch, Kairen ^c   Leake, Susan ^c   Karpavicius, Birute ^c   Haynes, Sue ^c   Mack, Tricia ^c   Chan, May ^c   Taylor, Yvonne ^c   Davies, John ^c   King, Paul ^c   Gruis, Nelleke A ^f   van Nieuwpoort, Frans A ^f   Out, Coby ^f   van der Drift, Clasine ^f   Bergman, Wilma ^f   Kukutsch, Nicole ^f   Bavinck, Jan Nico Bouwes ^f   Bakker, Bert ^f   van der Stoep, Nienke ^f   Ter Huurne, Jeanet ^f   van der Rhee, Han ^g   Bekkenk, Marcel ^h   Snels, Dyon ⁱ   van Praag, Marinus ⁱ   Brochez, Lieve ^j   Gerritsen, Rianne ^k   Crijns, Marianne ^l   Vasen, Hans ^m,n   Olsson, HÃ¥kan ^c   Ingvar, Christian ^c   Jönsson, Göran ^c   Borg, Ã…ke ^c   MÃ¥sbäck, Anna ^c   Lundgren, Lotta ^c   Baeckenhorn, Katja ^c   Nielsen, Kari ^c   Casslén, Anita Schmidt ^c   Helsing, Per ^o   Andresen, Per Arne ^o   Rootwelt, Helge ^o   Akslen, Lars A ^p   Molven, Anders ^p   Avril, Marie Françoise ^c   Paillerets, Brigitte Bressac De ^c   Chaudru, Valérie ^c   Chateigner, Nicolas ^c   Corda, Eve ^c   Jeannin, Patricia ^c   Lesueur, Fabienne ^c   de Lichy, Mahaut ^c   Maubec, Eve ^c   Mohamdi, Hamida ^c   Andry Benzaquen, Pascale ^c   Bachollet, Bertrand ^c   Bérard, Frédéric ^c   Berthet, Pascaline ^c   Boitier, Françoise ^c   Bonadona, Valérie ^c   Bonafé, Jean Louis ^c   Bonnetblanc, Jean Marie ^c   Cambazard, Frédéric ^c   Caron, Olivier ^c   Caux, Frédéric ^c   Chevrant Breton, Jacqueline ^c   Chompret, Agnès ^c   Dalle, Stéphane ^c   Demange, Liliane ^c   Dereure, Olivier ^c   Doré, Martin Xavier ^c   Doutre, Marie Sylvie ^c   Dugast, Catherine ^c   Faivre, Laurence ^c   Grange, Florent ^c   Humbert, Philippe ^c   Joly, Pascal ^c   Kerob, Delphine ^c   Lasset, Christine ^c   Leccia, Marie Thérèse ^c   Lenoir, Gilbert ^c   Leroux, Dominique ^c   Levang, Julien ^c   Lipsker, Dan ^c   Mansard, Sandrine ^c   Martin, Ludovic ^c   Martin Denavit, Tanguy ^c   Mateus, Christine ^c   Michel, Jean Loïc ^c   Morel, Patrice ^c   Olivier Faivre, Laurence ^c   Perrot, Jean Luc ^c   Robert, Caroline ^c   Ronger Savle, Sandra ^c   Sassolas, Bruno ^c   Souteyrand, Pierre ^c   Stoppa Lyonnet, Dominique ^c   Thomas, Luc ^c   Vabres, Pierre ^c   Wierzbicka, Eva ^c   Elder, David ^c   Kanetsky, Peter ^c   Knorr, Jillian ^c   Ming, Michael ^c   Mitra, Nandita ^c   Ruffin, Althea ^c   Van Belle, Patricia ^c   DÄ™bniak, Tadeusz ^c   LubiÅ„ski, Jan ^c   Mirecka, Aneta ^c   ErtmaÅ„ski, SÅ‚awomir ^c   Novakovic, Srdjan ^c   Hocevar, Marko ^c   Peric, Barbara ^c   Cerkovnik, Petra ^c   Höiom, Veronica ^c   Hansson, Johan ^c   Schmid, Helen ^c   Holland, Elizabeth A ^c   Azizi, Esther ^c   Galore Haskel, Gilli ^c   Friedman, Eitan ^c   Baron Epel, Orna ^c   Scope, Alon ^c   Pavlotsky, Felix ^c   Yakobson, Emanuel ^c   Cohen Manheim, Irit ^c   Laitman, Yael ^c   Milgrom, Roni ^c   Shimoni, Iris ^c   Kozlovaa, Vgeniya ^c   more..

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c University of Genoa ^*

^d UNIVERSITY OF GENOA   (Italy)

^e National Institute for Cancer Research   (Italy)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HAGA HOSPITAL   (Netherlands)

^h REINIER DE GRAAF HOSPITAL   (Netherlands)

ⁱ SINT FRANCISCUS GASTHUIS   (Netherlands)

^j GHENT UNIVERSITY HOSPITAL   (Belgium)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l RIJNLAND HOSPITAL   (Netherlands)

^m Stichting Melanoom   (Netherlands)

ⁿ Netherlands Foundation for the Detection of Hereditary Tumors   (Netherlands)

^o OSLO UNIVERSITY HOSPITAL   (Norway)

^p UNIVERSITY OF BERGEN   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BTLA GENE; BTNL2 GENE; CANCER SUSCEPTIBILITY; CBLB GENE; CCL17 GENE; CD160 GENE; CD274 GENE; CD28 GENE; CD40 GENE; CD40LG GENE; CD80 GENE; CD86 GENE; DENDRITIC CELL; DGKA GENE; FOXP3 GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ICOSLG GENE; IDO1 GENE; IL10 GENE; IL10RA GENE; IL10RB GENE; IL12A GENE; IL12B GENE; IL12RB1 GENE; IL17A GENE; IL17RA GENE; IL17RB GENE; IMMUNE DEFICIENCY; ITCH GENE; LGALS1 GENE; LGALS3 GENE; LILRB2 GENE; LILRB4 GENE; MELANOMA; PDCD1 GENE; RNF128 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TGFB1 GENE; TGFB2 GENE; TGFBR1 GENE; TGFBR2 GENE; TGFBR3 GENE; TNFRSF18 GENE; TREML2 GENE; VDR GENE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOSUPPRESSION; MELANOMA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84455172956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029451     Document Type: Article

References (46)

1. McCann J, (1999) Can skin cancers be minimized or prevented in organ transplant patients? J Natl Cancer Inst 91: 911-3.
2. Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F, (2006) Melanomas in renal transplant recipients. British Journal of Dermatology 154: 472-477.
3. Nathanson L, (1976) Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms. Natl Cancer Inst Monogr 44: 67-76.
4. Chang Y, Barrett J, Bishop D, Armstrong B, Bataille V, et al. (2009) Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. International journal of epidemiology 38: 814-30.
5. Donawho C, Muller H, Bucana C, Kripke M, (1996) Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms. The Journal of Immunology 157: 781.
6. Dunn G, Bruce A, Ikeda H, Old L, Schreiber R, (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nature immunology 3: 991-998.
7. Suciu-Foca N, Berloco P, Cortesini R, (2009) Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases. Human immunology 70: 277-80.
8. Polak ME, Borthwick NJ, Gabriel FG, Johnson P, Higgins B, et al. (2007) Mechanisms of local immunosuppression in cutaneous melanoma. Br J Cancer 96: 1879-87.
9. Schwartz R, (2003) T cell anergy. Annual Review of Immunology 21: 305-34.
10. Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P, (2006) Human t cell responses against melanoma. Annu Rev Immunol 24: 175-208.
11. Guilloux Y, Viret C, Gervois N, Le Drean E, Pandolfino MC, et al. (1994) Defective lymphokine production by most cd8+ and cd4+ tumor-specific t cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur J Immunol 24: 1966-73.
12. Zou W, (2006) Regulatory t cells, tumour immunity and immunotherapy. Nat Rev Immunol 6: 295-307.
13. Kryczek I, Liu R, Wang G, Wu K, Shu X, et al. (2009) Foxp3 defines regulatory t cells in human tumor and autoimmune disease. Cancer Res 69: 3995-4000.
14. Mourmouras V, Fimiani M, Rubegni P, Epistolato M, Malagnino V, et al. (2007) Evaluation of tumour-infiltrating cd4+ cd25+ foxp3+ regulatory t cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases. British Journal of Dermatology 157: 531-539.
15. Agarwala S, (2010) Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic t-lymphocyte antigen-4 blockade in advanced melanoma. Melanoma Research 20: 1.
16. Gajewski TF, (2007) Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin Cancer Res 13: 5256-61.
17. Bouwhuis MG, Gast A, Figl A, Eggermont AM, Hemminki K, et al. (2009) Polymorphisms in the cd28/ctla4/icos genes: role in malignant melanoma susceptibility and prognosis? Cancer Immunol Immunother 59: 303-312.
18. Nikolova PN, Pawelec GP, Mihailova SM, Ivanova MI, Myhailova AP, et al. (2007) Association of cytokine gene polymorphisms with malignant melanoma in caucasian population. Cancer Immunol Immunother 56: 371-9.
19. Howell WM, Turner SJ, Theaker JM, Bateman AC, (2003) Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 30: 409-14.
20. Schoof N, Von Bonin F, König I, Mössner R, Krüger U, et al. (2009) Distal and proximal interleukin (il)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case- control study. Genes and immunity 10: 586-590.
21. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, et al. (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41: 920-5.
22. Chasman DI, (2008) On the utility of gene set methods in genomewide association studies of quantitative traits. Genet Epidemiol 32: 658-68.
23. Hardy J, Singleton A, (2009) Genomewide association studies and human disease. N Engl J Med 360: 1759-68.
24. Peng G, Luo L, Siu H, Zhu Y, Hu P, et al. (2010) Gene and pathway-based second-wave analysis of genome-wide association studies. Eur J Hum Genet 18: 111-7.
25. Wang K, Li M, Bucan M, (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81.
26. Eleftherohorinou H, Wright V, Hoggart C, Hartikainen AL, Jarvelin MR, et al. (2009) Pathway analysis of GWAs provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One 4: e8068.
27. Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, et al. (2009) Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 85: 13-24.
28. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, et al. (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 3: e98.
29. Torkamani A, Topol EJ, Schork NJ, (2008) Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 92: 265-72.
30. Wang K, Zhang H, Kugathasan S, Annese V, Bradfield JP, et al. (2009) Diverse genome-wide association studies associate the il12/il23 pathway with crohn disease. Am J Hum Genet 84: 399-405.
31. Menashe I, Maeder D, Garcia-Closas M, Figueroa J, Bhattacharjee S, et al. (2010) Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Research 70: 4453.
32. Tintle NL, Borchers B, Brown M, Bekmetjev A, (2009) Comparing gene set analysis methods on single-nucleotide polymorphism data from genetic analysis workshop 16. BMC Proc 3 (Suppl 7): S96.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) Plink: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
34. R Development Core Team (2009) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available: URL http://www.R-project.org. ISBN 3-900051-07-0. (Accessed 2011 Dec 2.).
35. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, et al. (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nature Genetics 2011; 43: 1108-13.
36. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-50.
37. Efron B, Tibshirani R, (2007) On testing the significance of sets of genes. Ann Appl Stat 1: 107-129.
38. Nam D, Kim J, Kim S, Kim S, (2010) Gsa-snp: a general approach for gene set analysis of polymorphisms. Nucleic Acids Research 38 (Suppl): W749-54.
39. Chen L, Hutter C, Potter J, Liu Y, Prentice R, et al. (2010) Insights into colon cancer etiology via a regularized approach to gene set analysis of GWAS data. The American Journal of Human Genetics 86: 860-871.
40. Mellor A, Munn D, (2004) Ido expression by dendritic cells: tolerance and tryptophan catabolism. Nature Reviews Immunology 4: 762-774.
41. Munn D, Mellor A, (2004) Ido and tolerance to tumors. Trends in Molecular Medicine 10: 15-18.
42. Arefayene M, Mamidipalli S, Philips S, Cao D, Flockhart D, et al. (2006) Identification of functional genetic variants of the indoleamine 2, 3 dioxygenase gene. Proceedings of the American Association for Cancer Research 2006: 1119.
43. Liu F, Rabinovich G, (2005) Galectins as modulators of tumour progression. Nature Reviews Cancer 5: 29-41.
44. Hoek K, Schlegel N, Eichhoff O, Widmer D, Praetorius C, et al. (2008) Novel mitf targets identified using a two-step dna microarray strategy. Pigment Cell & Melanoma Research 21: 665-676.
45. Vereecken P, Awada A, Suciu S, Castro G, Morandini R, et al. (2009) Evaluation of the prognostic significance of serum galectin-3 in American joint committee on cancer stage iii and stage iv melanoma patients. Melanoma Research 19: 316.
46. Gorelik L, Flavell R, (2002) Transforming growth factor-β in t-cell biology. Nature Reviews Immunology 2: 46-53.